Validation of Immune Dysfunction in Model of Social Stress: Implications for Major Depression Disorder in Veterans
社会压力模型中免疫功能障碍的验证:对退伍军人重度抑郁症的影响
基本信息
- 批准号:10293590
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAffinity ChromatographyAfghanistanAnhedoniaAnimalsAntidepressive AgentsAnxietyAreaArterial Fatty StreakAstrocytesAutomobile DrivingAwardBacterial Artificial ChromosomesBehaviorBehavioralBioinformaticsBloodBlood - brain barrier anatomyBlood VesselsBrainBrain regionCardiovascular DiseasesCellsChronicChronic stressClinical ResearchCoupledCytometryDataDevelopmentDisease remissionEndothelial CellsEndotheliumEpithelialExposure toGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGoalsHealthHumanImmuneImmune System DiseasesImmune signalingImmunologicsImpairmentIndividual DifferencesInfiltrationInflammationInflammatoryInflammatory ResponseInnate Immune SystemInterleukin-6IraqKnowledgeLeadLinkMajor Depressive DisorderMeasuresMediatingMental DepressionMessenger RNAModelingMonitorMood DisordersMoodsMorbidity - disease rateMusNucleus AccumbensPathogenesisPathologyPatientsPatternPeripheralPharmacological TreatmentPhenotypePhysical FunctionPlayPost-Traumatic Stress DisordersPredispositionPrevalenceProteinsPsychological ModelsPsychological StressPublicationsRecruitment ActivityReportingRibosomesRoleRuptureSeriesSignal TransductionStressStructureSurface AntigensSymptomsTestingTherapeuticTight JunctionsTranslatingTumor-infiltrating immune cellsValidationVeteransWithdrawalWorkanxiety-like behaviorbasebehavioral phenotypingblood-brain barrier permeabilizationbrain parenchymabrain tissuecardiovascular risk factorcytokinedepression modelinnovationinterestmonocytemortalityneural circuitneurovascularneurovascular injurynovelnovel therapeutic interventionpre-clinicalpreclinical studypreventpsychologicrecruitresilienceresponsesevere mental illnesssocialsocial defeatsocial stresssymptomatologytranscriptome sequencingtranscriptomicsvalidation studies
项目摘要
Project Summary/Abstract
At least 30% of Afghanistan and Iraq veterans are affected by Major Depressive Disorder (MDD) and 20% are
affected by post-traumatic stress disorder (PTSD) and other stress-related mood disorders. Currently existing
pharmacological treatments elicit temporary remission in <50% of patients; thus, there is an urgent need for
novel therapeutic approaches to target MDD and psychological stress-related mood disorders. The prevalence
of MDD is two- to threefold higher in patients with cardiovascular disease and MDD is associated with 80%
increased risk of cardiovascular morbidity and mortality. Clinical studies report higher levels of circulating pro-
inflammatory cytokines in patients with MDD and has been replicated in preclinical animal studies of
depression. Individual differences in the modulation of cytokine release (most notably IL-6) are associated with
susceptibility vs. resilience to chronic social stress in mice. Chronic inflammation and increases in circulatory
pro-inflammatory cytokines associated with stress-induced depression is linked with atherosclerotic plaque
formation, progression, and rupture, likely contributing to the pathogenesis of cardiovascular disease. Indeed,
immune modulatory approaches to neutralize inflammatory cytokines in the periphery produce antidepressant-
like behavioral effects following Chronic Social Defeat Stress (CSDS) in mice as well as in humans with
depression and chronic inflammation. The concept of resilience, the ability to maintain normal psychological
and physical functioning to avoid serious mental illness has topic of significant interest in Veterans during and
post-deployment after exposure to psychological stress.Recently, CSDS-associated depression has been
linked to impairment of the blood brain barrier (BBB), a series of protective layers including endothelial cells
and astrocytes that plays a critical role in maintaining vascular impermeability between the periphery and brain
parenchyma. The proposed validation studies implicate that impairment of the BBB may be causally
associated with stress-induced mood disorders. In particular, we will validate and expand our understanding
how stress influences the region-dependent impairment of the BBB in stress-induced mood disorders, as
previously reported by our collaborators Scott Russo, Anne Schaefer, and Miriam Merad in their publication
“Social stress induces neurovascular pathology promoting depression”. Using a well-characterized CSDS
model of psychological stress in mice that recapitulates many of the symptoms of MDD including social
withdrawal, anhedonia, and anxiety, we will explore through novel technological approaches how chronic
psychological stress impairs the BBB. In particular, we will utilize a novel endothelial-specific Translating
Ribosome Affinity Purification (TRAP) mouse to explore stress-induced transcriptional patterns in multiple
mood-related brain regions to determine transcriptomic patterns to psychological stress. To further explore how
psychological stress impairs the BBB, we will utilize an innovative mass cytometry (CyTOF) to determine the
immune cell profiles in the periphery and brain tissue of susceptible vs. resilient mice and understand how
psychological stress mobilizes the innate immune system and causes infiltration of cytokines into the brain.
In summary, the proposal in this Merit Review Award for Validation Studies is of importance to Veteran Health.
This VA Merit Review Award is to validate recent findings by our collaborators showing that psychological
stress in a model of depression impairs BBB permeability and expand our knowledge into how stress induces
region-specific endothelial gene expression changes, leading to vascular damage and depression-linked
chronic inflammation. The findings of our studies will provide evidence for preclinical studies for novel
therapeutic approaches for treating stress-related MDD for Veterans.
项目总结/摘要
至少有30%的阿富汗和伊拉克退伍军人受到严重抑郁症(MDD)的影响,20%的人
受创伤后应激障碍(PTSD)和其他与压力有关的情绪障碍的影响。当前存在
药物治疗在<50%的患者中引起暂时缓解;因此,迫切需要
针对MDD和心理压力相关情绪障碍的新治疗方法。之时尚
心血管疾病患者的抑郁症发病率高出两到三倍,其中80%与抑郁症有关
心血管疾病发病率和死亡率的风险增加。临床研究报告称,
在MDD患者中的炎性细胞因子,并已在临床前动物研究中复制,
萧条调节细胞因子释放(最显著的是IL-6)的个体差异与
小鼠对慢性社会压力的易感性与恢复力。慢性炎症和循环增加
与压力诱导的抑郁症相关的促炎细胞因子与动脉粥样硬化斑块有关
形成、进展和破裂,可能有助于心血管疾病的发病机制。的确,
免疫调节方法中和外周的炎性细胞因子产生抗抑郁药,
就像慢性社会失败压力(CSDS)对小鼠和人类的行为影响一样,
抑郁症和慢性炎症。心理韧性的概念,保持正常心理的能力
和身体功能,以避免严重的精神疾病有重大利益的主题,在退伍军人期间,
最近,与CSD相关的抑郁症已经被发现,
与血脑屏障(BBB)受损有关,血脑屏障是一系列保护层,包括内皮细胞
和星形胶质细胞,在维持外周和大脑之间的血管不渗透性方面起着关键作用
薄壁组织拟议的验证研究表明,BBB的损害可能是因果关系,
与压力引起的情绪障碍有关特别是,我们将验证和扩大我们的理解,
应激如何影响应激诱导的心境障碍中BBB的区域依赖性损伤,
我们的合作者Scott Russo,Anne Schaefer和Miriam Merad在他们的出版物中先前报道过
社会压力导致神经血管病理学促进抑郁症。使用特征良好的CSDS
小鼠心理应激模型,重现了MDD的许多症状,包括社会
退缩,快感缺乏和焦虑,我们将通过新的技术方法探索慢性
心理压力损害BBB。特别是,我们将利用一种新的内皮特异性翻译,
核糖体亲和纯化(TRAP)小鼠,以探索多种应激诱导的转录模式
情绪相关的大脑区域,以确定转录模式的心理压力。为了进一步探索
心理压力损害血脑屏障,我们将利用创新的质谱仪(CyTOF)来确定
免疫细胞在易感小鼠与弹性小鼠的外周和脑组织中的分布,并了解如何
心理压力调动了先天免疫系统并导致细胞因子渗入大脑。
总而言之,这项验证研究优秀评审奖的提案对退伍军人健康至关重要。
这个VA优秀评论奖是为了验证我们的合作者最近的发现,表明心理
抑郁症模型中的应激损害BBB渗透性,并扩展了我们对应激如何诱导
区域特异性内皮基因表达改变,导致血管损伤和抑郁症相关
慢性炎症。我们的研究结果将为新的临床前研究提供证据。
治疗退伍军人压力相关抑郁症的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Giulio Maria Pasinetti其他文献
Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease
- DOI:
10.1016/0169-328x(95)00097-c - 发表时间:
1995-10-01 - 期刊:
- 影响因子:
- 作者:
Philippe Bertrand;Judes Poirier;Tomiichiro Oda;Caleb E. Finch;Giulio Maria Pasinetti - 通讯作者:
Giulio Maria Pasinetti
Differential susceptibility to repeated social stress induces synaptic plasticity impairment and cognitive deficit in the 5xFAD mouse model
对重复社会应激的差异易感性在 5xFAD 小鼠模型中诱导突触可塑性损伤和认知缺陷
- DOI:
10.1016/j.pneurobio.2025.102797 - 发表时间:
2025-08-01 - 期刊:
- 影响因子:6.100
- 作者:
Eun-Jeong Yang;Md Al Rahim;Sibilla Masieri;Giulio Maria Pasinetti - 通讯作者:
Giulio Maria Pasinetti
The Role of the Neural Exposome as a Novel Strategy to Identify and Mitigate Health Inequities in Alzheimer’s Disease and Related Dementias
- DOI:
10.1007/s12035-024-04339-6 - 发表时间:
2024-07-05 - 期刊:
- 影响因子:4.300
- 作者:
Ravid Granov;Skyler Vedad;Shu-Han Wang;Andrea Durham;Divyash Shah;Giulio Maria Pasinetti - 通讯作者:
Giulio Maria Pasinetti
61 Repurposing anti-hypertensive drugs for Alzheimer's disease
- DOI:
10.1016/j.neurobiolaging.2012.01.079 - 发表时间:
2012-05-01 - 期刊:
- 影响因子:
- 作者:
Giulio Maria Pasinetti;P. Rosenberg - 通讯作者:
P. Rosenberg
P27-030-23 Flavonoids Ameliorate Stress-Induced Depression by Preventing NLRP3 Inflammasome Priming
- DOI:
10.1016/j.cdnut.2023.101237 - 发表时间:
2023-07-01 - 期刊:
- 影响因子:
- 作者:
Giulio Maria Pasinetti;Eun-Jeong Yang - 通讯作者:
Eun-Jeong Yang
Giulio Maria Pasinetti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Giulio Maria Pasinetti', 18)}}的其他基金
Validation of Immune Dysfunction in Model of Social Stress: Implications for Major Depression Disorder in Veterans
社会压力模型中免疫功能障碍的验证:对退伍军人重度抑郁症的影响
- 批准号:
10618776 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Validation of Immune Dysfunction in Model of Social Stress: Implications for Major Depression Disorder in Veterans
社会压力模型中免疫功能障碍的验证:对退伍军人重度抑郁症的影响
- 批准号:
10016566 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Suppression of Immune Signatures of Stress by Polyphenols Supplements
多酚补充剂抑制压力的免疫特征
- 批准号:
10447073 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Suppression of Immune Signatures of Stress by Polyphenols Supplements
多酚补充剂抑制压力的免疫特征
- 批准号:
10671048 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Suppression of Immune Signatures of Stress by Polyphenols Supplements
多酚补充剂抑制压力的免疫特征
- 批准号:
10200686 - 财政年份:2020
- 资助金额:
-- - 项目类别:
CMA: Immune/inflammatory priming in exacerbating responses to GWVI stressors: implications for GWVI treatments
CMA:免疫/炎症引发加剧对 GWVI 应激源的反应:对 GWVI 治疗的影响
- 批准号:
10752604 - 财政年份:2019
- 资助金额:
-- - 项目类别:
CMA: Immune/inflammatory priming in exacerbating responses to GWVI stressors: implications for GWVI treatments
CMA:免疫/炎症引发加剧对 GWVI 应激源的反应:对 GWVI 治疗的影响
- 批准号:
10266035 - 财政年份:2019
- 资助金额:
-- - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
-- - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
-- - 项目类别:
Collaborative Research and Development Grants